Provision of Nasal Naloxone

A Tender Notice
by MINISTRY OF JUSTICE

Source
Find a Tender
Type
Contract (Goods)
Duration
5 year
Value
£3M
Sector
HEALTH
Published
24 Jul 2025
Delivery
24 Nov 2025 to 23 Nov 2030
Deadline
19 Aug 2025 11:00

Concepts

Location

United Kingdom:

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

The provision including supply and delivery of nasal Naloxone. Nasal Naloxone supplied must be licensed for use in the UK, compliant with Medicines and Healthcare products Regulatory Agency (MHRA) standards and of a formulation licensed for use on adults and adolescents aged 14 and over. Timely delivery is required to HMPPS settings across England and Wales, including Public Sector (HMPPS) and Privately Managed Prisons, Youth Custody sites, Approved Premises (AP), Independent Approved Premises (IAPs), and Probation Offices and contact centers.

Renewal Options

Special Term 1: This is a zero-volume guarantee provision, and all indicative volumes are for illustrative purposes only. Actual volumes may fluctuate due to the unpredictable nature of this requirement. The Authority has identified a known risk that there is the possibility that the required quantities may significantly increase due to [e.g. policy changes, external demand, or operational needs]. While this risk is acknowledged, it cannot be fully quantified or addressed at the time of Contract award. In the event this risk materialises, the Authority reserves the right to modify the contract in accordance with the Procurement Act 2023, subject to the conditions set out in Regulation 18(2)(z) and Schedule. Special Term 2: Collection and disposal of expired nasal Naloxone Kits is not a requirement of the Contract at the time of Tender, however, if the Supplier possess the capability to collect and dispose of expired nasal Naloxone Kits, in accordance with relevant waste disposal regulations, this may be a service that the Authority chooses to utilise in the future. Should the Supplier possess the capability to delivery this service, activation would be agreed upon separately and in advance. The Authority reserves the right to determine whether to activate this service based on operational needs.

Award Criteria

Technical Overall Technical Score will be determined by the sum of the weighted scores for the following Technical questions (question weighting in brackets): Service Delivery (40%) Quality Assurance (30%) Contract Performance and Management (20%) Social Value (10%)
Commercial _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains